Dr Patrick Vallance

President, R&D

Dr Patrick Vallance
Patrick Vallance

Dr Patrick Vallance - download image (JPG)

Patrick joined GSK in 2006 as Head of Drug Discovery and was subsequently appointed Senior Vice President, Medicines Discovery and Development. He has been a member of GSK’s Corporate Executive Team since 2010 and was appointed President, R&D in January 2012. Patrick joined the GSK Board on 1 January 2017.

Prior to joining GSK, Patrick was a clinical academic and, as Professor of Medicine, led the Division of Medicine at University College London. He has over 20 years’ experience of research clinical medicine, general internal medicine, cardiovascular medicine and clinical pharmacology. He was elected to the Academy of Medical Sciences in 1999, and as a Fellow of The Royal Society in 2017.

Patrick is a Non-Executive Director of Genome Research Limited and UK Biobank.